which glp-1 agonists have cardiovascular benefit GLP-1RAs reduce deaths in patients with CKM comorbidity | Duke Clinical Research Institute posted on the topic GLP-1 Drugs & What They

Safety and Tolerability: What Is and Isnt Known Safety is often where the two compounds are oversold as side-effect-free. The accurate picture is narrower: both look well tolerated in the limited settings that have been studied, and both lack long-term human safety data

The maximum dose permitted by health authorities is 3000 mg

At typical room temperature it keeps its quality for roughly 7 to 10 days

June 2, 2025: Plaintiffs Attorneys Shed Light on Key Issue in Mounjaro Lawsuit Consumers have sued Mounjaros manufacturer, Eli Lilly, and other pharmaceutical companies because they allege their GLP-1 products are causing gastroparesis, where the persons stomach stops digesting food or digests food very slowly